Fucoidan Ameliorates Renal Injury-Related Calcium-Phosphorus Metabolic Disorder and Bone Abnormality in the CKD–MBD Model Rats by Targeting FGF23-Klotho Signaling Axis
CORRECTION article
Corrigendum: [Fucoidan Ameliorates Renal Injury-Related Calcium-Phosphorus Metabolic Disorder and Bone Abnormality in the CKD-MBD Model Rats by Targeting FGF23-Klotho Signaling Axis]
Provisionally accepted- 1 Department of Traditional Chinese Medicine, Nanjing Drum Tower Hospital Clinical College of Nanjing University of Chinese Medicine, Nanjing, Liaoning Province, China
- 2 Nanjing University, Nanjing, China
Keywords: fucoidan, Chronic kidney disease-mineral and bone disorder, FGF23-Klotho signaling axis, phosphorus reabsorption, ERK1/2-SGK1-NHERF-1-NaPi-2a pathway
Received: 10 Jun 2024; Accepted: 25 Jun 2024.
Copyright: © 2024 Liu, Chong, Yuan, Liu, Yang, Wang, FANG, Wu, Wang, TU, Wan, Wan and Wu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Yi-Gang Wan, Nanjing University, Nanjing, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.